Clinical Trial

Digital Remote Management for Care and Continuous Optimization Versus Usual Care to Reduce Risk of Atherosclerotic Cardiovascular Diseases (DigiCare-ASCVD)

Study acronym: DigiCare-ASCVD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The DigiCare-ASCVD study is an investigator-initiated, multicenter, open-label, parallel-group randomized controlled trial. It aims to evaluated whether digital remote management is superior to usual care in reducing risk of atherosclerotic cardiovascular diseases and improving blood pressure control, glycemic control, lipids control, medication compliance and lifestyle.
Trial Details
NCT Number NCT07332468
Lead Sponsor Beijing Anzhen Hospital
Conditions Atherosclerotic Cardiovascular Diseases
Enrollment 790 participants
Start Date 2026-01
Primary Completion 2027-03 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-01-12